These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Fibroblast growth factor 21 improves hepatic insulin sensitivity by inhibiting mammalian target of rapamycin complex 1 in mice. Gong Q; Hu Z; Zhang F; Cui A; Chen X; Jiang H; Gao J; Chen X; Han Y; Liang Q; Ye D; Shi L; Chin YE; Wang Y; Xiao H; Guo F; Liu Y; Zang M; Xu A; Li Y Hepatology; 2016 Aug; 64(2):425-38. PubMed ID: 26926384 [TBL] [Abstract][Full Text] [Related]
12. TSC1/TSC2 inactivation inhibits AKT through mTORC1-dependent up-regulation of STAT3-PTEN cascade. Zha X; Hu Z; He S; Wang F; Shen H; Zhang H Cancer Lett; 2011 Dec; 313(2):211-7. PubMed ID: 22055460 [TBL] [Abstract][Full Text] [Related]
13. TSC but not PTEN loss in starving cones of retinitis pigmentosa mice leads to an autophagy defect and mTORC1 dissociation from the lysosome. Venkatesh A; Ma S; Punzo C Cell Death Dis; 2016 Jun; 7(6):e2279. PubMed ID: 27362797 [TBL] [Abstract][Full Text] [Related]
14. Hepatic mTOR-AKT2-Insig2 signaling pathway contributes to the improvement of hepatic steatosis after Roux-en-Y Gastric Bypass in mice. Pan Q; Qin T; Gao Y; Li S; Li D; Peng M; Zhai H; Xu G Biochim Biophys Acta Mol Basis Dis; 2019 Mar; 1865(3):525-534. PubMed ID: 30562559 [TBL] [Abstract][Full Text] [Related]
15. Chronic inhibition of the mTORC1/S6K1 pathway increases insulin-induced PI3K activity but inhibits Akt2 and glucose transport stimulation in 3T3-L1 adipocytes. Veilleux A; Houde VP; Bellmann K; Marette A Mol Endocrinol; 2010 Apr; 24(4):766-78. PubMed ID: 20203102 [TBL] [Abstract][Full Text] [Related]
16. Hepatic mTORC1 controls locomotor activity, body temperature, and lipid metabolism through FGF21. Cornu M; Oppliger W; Albert V; Robitaille AM; Trapani F; Quagliata L; Fuhrer T; Sauer U; Terracciano L; Hall MN Proc Natl Acad Sci U S A; 2014 Aug; 111(32):11592-9. PubMed ID: 25082895 [TBL] [Abstract][Full Text] [Related]
17. Hyperactivation of mammalian target of rapamycin complex 1 (mTORC1) promotes breast cancer progression through enhancing glucose starvation-induced autophagy and Akt signaling. Chen Y; Wei H; Liu F; Guan JL J Biol Chem; 2014 Jan; 289(2):1164-73. PubMed ID: 24275666 [TBL] [Abstract][Full Text] [Related]
18. Ellagic acid ameliorates AKT-driven hepatic steatosis in mice by suppressing de novo lipogenesis via the AKT/SREBP-1/FASN pathway. Zhang C; Hu J; Sheng L; Yuan M; Wu Y; Chen L; Wang G; Qiu Z Food Funct; 2019 Jun; 10(6):3410-3420. PubMed ID: 31123744 [TBL] [Abstract][Full Text] [Related]
19. The TSC1-TSC2 complex is required for proper activation of mTOR complex 2. Huang J; Dibble CC; Matsuzaki M; Manning BD Mol Cell Biol; 2008 Jun; 28(12):4104-15. PubMed ID: 18411301 [TBL] [Abstract][Full Text] [Related]
20. Activation of Liver mTORC1 Protects Against NASH via Dual Regulation of VLDL-TAG Secretion and De Novo Lipogenesis. Uehara K; Sostre-Colón J; Gavin M; Santoleri D; Leonard KA; Jacobs RL; Titchenell PM Cell Mol Gastroenterol Hepatol; 2022; 13(6):1625-1647. PubMed ID: 35240344 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]